Cargando…
Prolonged Exposure to Oxaliplatin during HIPEC Improves Effectiveness in a Preclinical Micrometastasis Model
SIMPLE SUMMARY: Absence of survival benefits when adding hyperthermic intraperitoneal chemotherapy (HIPEC) with oxaliplatin to cytoreductive surgery in peritoneal metastasis from colorectal cancer has recently been shown in the randomized controlled PRODIGE 7 trial. We therefore aimed to investigate...
Autores principales: | Seyfried, Nick, Yurttas, Can, Burkard, Markus, Oswald, Benedikt, Tolios, Alexander, Herster, Franziska, Kauer, Joseph, Jäger, Tarkan, Königsrainer, Ingmar, Thiel, Karolin, Quante, Markus, Rammensee, Hans-Georg, Venturelli, Sascha, Schwab, Matthias, Königsrainer, Alfred, Beckert, Stefan, Löffler, Markus W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909393/ https://www.ncbi.nlm.nih.gov/pubmed/35267468 http://dx.doi.org/10.3390/cancers14051158 |
Ejemplares similares
-
Systematic Review of Variations in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Metastasis from Colorectal Cancer
por: Yurttas, Can, et al.
Publicado: (2018) -
ASO Author Reflections: First Do No Harm—Revisiting Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Trials to Reduce the Risk of Peritoneal Metastasis
por: Yurttas, Can, et al.
Publicado: (2021) -
A Prospective, Phase I/II, Open-Label Pilot Trial to Assess the Safety of Hyperthermic Intraperitoneal Chemotherapy After Oncological Resection of Pancreatic Adenocarcinoma
por: Yurttas, Can, et al.
Publicado: (2021) -
Twelve-Year Single Center Experience Shows Safe Implementation of Developed Peritoneal Surface Malignancy Treatment Protocols for Gastrointestinal and Gynecological Primary Tumors
por: Horvath, Philipp, et al.
Publicado: (2021) -
Reply to “Letter to the Editor on Yurttas C et al. Limitations of laparoscopy to assess the peritoneal cancer index and eligibility for cytoreductive surgery with HIPEC in peritoneal metastasis”
por: Yurttas, Can, et al.
Publicado: (2023)